Delivery Order SPE2DB22D1202-SPE2DB24FVFD1

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566188546 SAVELLA 12.5 MG TABLET 60S. The firm-fixed-price Delivery Order, valued at $3,517.32, does not have a set-aside designation. The contract has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $4,205.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567557934 - SAVELLA 25 MG TABLET 60S, with a period of performance through March 11, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of SAVELLA 50 MG TABLET 60S. The contract is a Delivery Order valued at $2,815.09 with a firm fixed price and an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,180.60 fixed-price delivery order supports the supply of SAVELLA 25 MG TABLET 60S to the DLA. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Firm Fixed Price delivery order valued at $3,021.65. The contract is for the supply of the pharmaceutical product SAVELLA 25 MG TABLET 60S to the Defense Logistics Agency (DLA), which is a defense agency. The contract has an ultimate completion date of May 30, 2024 and was awarded on May 29, 2024. This appears to be a task order issued under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FECK5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SAVELLA 50 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $8,904.95 and a completion date of March 11, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,037.65, is for the delivery of SAVELLA 50 MG TABLET 60S medical supplies. The contract is a Firm Fixed Price Delivery Order, with a period of performance through January 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Savella 100 mg tablets. The award has a ceiling value of $4,469.85 and an ultimate completion date of April 7, 2025. This contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,019.82, is for the delivery of Savella 12.5 mg tablets to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $7,394.57 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the provision of SAVELLA 50 MG TABLET 60S, a pharmaceutical product, with a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVFD1
    Delivery Order

This federal contract award, valued at $1,797.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565018970 - SAVELLA 25 MG TABLET 60S, a prescription medication.

The contract is a Delivery Order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

The contract does not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitiveness in the federal pharmaceutical supply market. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/26/24, 9:04 AM